John Wiley & Sons, Inc. (WLY) Stock Price & How to Invest
Last updated July 2026
Short answer
WLY is the Class A stock of John Wiley & Sons, the Hoboken publisher that after 200 years now earns roughly two-thirds of its ~$1.68 billion in annual revenue from peer-reviewed scientific research rather than from textbooks. Owning it means owning a deep archive of vetted journal content that is being repriced as licensing inventory for AI developers, attached to a Learning segment that has been shrinking for two years.
WLY stock price
As of 2026-08-25, John Wiley & Sons, Inc. (WLY) last closed at $53.89, up 34.8% over the past year. Over the past 52 weeks it has traded between $28.79 and $55.72.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or John Wiley & Sons, Inc.'s investor relations page. Walnut is informational, not investment advice.
What does John Wiley & Sons, Inc. (WLY) do?
John Wiley & Sons is a scholarly publisher and research-intelligence company headquartered at 111 River Street in Hoboken, New Jersey, with roughly 4,500 employees worldwide and a corporate history running back to 1807. It reports in two segments. Research, at ~$1.13 billion of fiscal 2026 revenue, publishes peer-reviewed STM journals and sells content platforms, publishing services and audience solutions to universities, corporations, governments and academic societies; the Wiley Online Library and the Atypon platform business sit here. Learning, at ~$547 million, covers the Academic and Professional lines: scientific and professional books, digital courseware, the For Dummies imprint, and workplace assessment products such as Everything DiSC and The Five Behaviors. About 85% of revenue is digital and roughly 48% is recurring under subscriptions or contractually obligated agreements. The company also runs a dual-class structure that has been in place for decades, with Class B largely held by the Wiley family.
The investment picture is a company that has finished cleaning house and is now betting the story on two engines. Fiscal 2026 (the year ended April 30, 2026) produced ~$1.68 billion of revenue, essentially flat, but operating income rose ~25% to ~$277 million and adjusted EBITDA margin expanded ~220 basis points to a record ~26.2% as divestitures of non-core units such as CrossKnowledge and University Services worked through and restructuring savings landed. Adjusted EPS of ~$4.19 was up ~15%, free cash flow rose ~55% to ~$195 million, and management guided fiscal 2027 adjusted EPS to ~$4.60 to ~$5.05. On top of that, Wiley closed the ~$452 million all-cash purchase of UK scholarly publisher Emerald Publishing on June 1, 2026, taking its journal portfolio to ~2,500 titles. The central question is straightforward: AI licensing revenue reached ~$49 million in fiscal 2026 and passed ~$110 million cumulatively, which is real but small against a $1.68 billion base, and the same technology that is buying Wiley's content is a plausible substitute for the professional and academic books that Learning sells.
What's driving John Wiley & Sons, Inc. (WLY)?
1. Research publishing scale, now enlarged by Emerald
Research grew ~5% in fiscal 2026 (~4% at constant currency) on record article submissions and output, with gold open access and recurring institutional agreements doing most of the work. The Emerald acquisition, closed June 1, 2026 for £337.5 million (~$452 million), adds nearly 500 journal brands concentrated in economics, business, finance and the social sciences and is expected to contribute ~$78 million of revenue in fiscal 2027. Wiley bought it at ~7x adjusted EBITDA including targeted synergies and expects ~$30 million of annual run-rate cost savings by year three.
2. AI and data licensing as the second engine
Wiley's pitch to AI developers is that peer-reviewed content is scarce, verifiable and legally clean, which is the opposite of scraped web text. Fiscal 2026 AI revenue was ~$49 million, up ~23%, with named partnerships including IQVIA and OpenEvidence and a growing list of corporate R&D customers. The company created a Chief AI and Data Analytics Officer role in January 2026 to commercialize AI-ready content and data products, and management has emphasized the shift from one-off training deals toward recurring licensing.
3. Margin and cash conversion after the cleanup
Three years of divestitures and restructuring have left a smaller, more profitable company. Adjusted operating margin hit a record ~17.7% in fiscal 2026, corporate expenses fell ~14%, net debt to EBITDA improved to ~1.4x from ~1.8x, and free cash flow of ~$195 million funded a record ~$174 million of dividends and buybacks including ~$100 million of repurchases. Guidance calls for adjusted EBITDA margin of ~26.5% to ~27.5% in fiscal 2027 and free cash flow of ~$205 million, absorbing Emerald dilution of ~$15 million in year one.
4. Whether Learning stops falling
Learning revenue fell ~7% in fiscal 2026 to ~$547 million on retail channel softness, macro pressure on education budgets and a tough comparison against prior-year AI licensing. Margins there still improved to ~38.0% on cost actions, so the segment remains a meaningful cash contributor even while shrinking. Fiscal 2027 guidance assumes improvement in Learning, which makes that assumption one of the more testable parts of the outlook.
What are the risks to John Wiley & Sons, Inc. (WLY)?
The clearest tension is that generative AI is both Wiley's newest customer and a credible substitute for parts of what it sells, particularly professional reference and courseware in Learning. AI licensing revenue is also lumpy and negotiated deal by deal, so a strong year can flatter comparisons that the next year has to lap, which is exactly what happened inside Learning in fiscal 2026. Emerald was funded with cash and a draw on the revolving credit facility, which pushes net debt above the ~$608 million reported at fiscal year end and puts integration risk on a company that has spent three years simplifying. Roughly half of revenue comes from outside the United States and Emerald generates ~85% of its revenue outside North America, so reported results carry real currency sensitivity, and open access economics continue to shift pricing power toward funders and institutions. Governance is a standing objection: ISS and Glass Lewis both recommended withholding votes from a Class A director nominee in 2025 over the dual-class structure and its lack of a sunset provision, and Class A holders elect only 30% of the board regardless of how many shares they own.
Is WLY a buy or a sell?
We give no verdict on John Wiley & Sons, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. Research publishing scale, now enlarged by Emerald. Research grew ~5% in fiscal 2026 (~4% at constant currency) on record article submissions and output, with gold open access and recurring institutional agreements doing most of the work.
The case against. The clearest tension is that generative AI is both Wiley's newest customer and a credible substitute for parts of what it sells, particularly professional reference and courseware in Learning.
Read the full bull and bear case on WLY, including what would have to change to break either one. Walnut is not an investment adviser.
How is John Wiley & Sons, Inc. (WLY) valued? (approximate, August 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see John Wiley & Sons, Inc.'s investor relations page or your broker.
- Revenue (FY2026, ended April 2026): ~$1.68 billion, roughly flat year over year
- Research segment revenue: ~$1.13 billion, up ~5%
- Adjusted EBITDA: ~$440 million, ~26.2% margin (record)
- Adjusted EPS: ~$4.19 (GAAP diluted ~$4.16)
- Free cash flow: ~$195 million, up ~55%
- Market capitalization: ~$2.7 billion across both share classes (~$54 per Class A share)
At ~$54, WLY trades near ~13x fiscal 2026 adjusted EPS and roughly ~11x the midpoint of the ~$4.60 to ~$5.05 fiscal 2027 guidance range, a discount to information-services peers that reflects flat revenue and the Learning drag. The stock has been volatile in a way the financials are not: the 52-week range runs from ~$28 to ~$57, so most of the move has come from how the market is choosing to value AI content licensing rather than from reported results. Wiley raised its dividend for a 32nd consecutive year in fiscal 2026 at ~$1.42 per share annualized, and it reports on an April fiscal year end, so the calendar is a quarter offset from most comparables.
Who competes with John Wiley & Sons, Inc. (WLY)?
Scholarly and STM publishers
RELX (Elsevier), Springer Nature, Taylor & Francis (Informa), SAGE and the university presses compete for the same journals, editorial boards and institutional subscription budgets. Scale matters here because library consortia negotiate portfolio-wide agreements, and article volume drives the open access model, which is why the Emerald deal was framed around title count. Elsevier is larger and further along in selling analytics on top of content, which sets the benchmark Wiley's Research Solutions line is measured against.
Research intelligence and workflow data
Clarivate, Digital Science, Wolters Kluwer and Thomson Reuters sell the metadata, citation analytics and workflow tools that sit alongside the literature. This is where Wiley's Research Solutions and its new AI and data analytics push compete, and it is a higher-multiple business than publishing, which is part of why management keeps separating the two in its reporting.
Education and professional publishing
Pearson, McGraw Hill, Cengage and Oxford University Press compete with the Learning segment for courseware and textbook adoptions, while free or low-cost AI tutors and open educational resources pressure the whole category. Learning's ~7% decline in fiscal 2026 is the visible result of that pressure, and its ~38% adjusted EBITDA margin is why the segment still matters to the consolidated numbers.
What stocks are similar to John Wiley & Sons, Inc. (WLY)?
Other names that sit close to WLY: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.
How to invest in John Wiley & Sons, Inc. (WLY)
There are three common ways to get WLY exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so WLY sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where WLY fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on John Wiley & Sons, Inc. (WLY)
Wiley is a low-growth publisher whose research archive has become AI licensing inventory, and the stock turns on whether that second engine scales faster than Learning fades.
More on John Wiley & Sons, Inc. (WLY)
Whether WLY is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is WLY a buy or a sell?, and where the stock could go from here in the WLY stock forecast.
For income investors, whether WLY pays a dividend and how the payout looks is covered in does WLY pay a dividend? And to weigh WLY against a peer, read the full side-by-side comparisons: WLY vs STM and WLY vs TRI.
Wondering how WLY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in John Wiley & Sons, Inc. with AI
Connect the broker you already use and ask Walnut's AI how WLY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What does John Wiley & Sons actually do?
+
It publishes and licenses authoritative content. The Research segment, ~$1.13 billion of fiscal 2026 revenue, publishes peer-reviewed scientific, technical and medical journals and sells platforms and publishing services to universities, corporations and academic societies. The Learning segment, ~$547 million, sells professional and academic books, digital courseware and workplace assessments. About 85% of revenue is digital.
What is the difference between WLY and WLYB?
+
They are two classes of the same company, both listed on the NYSE. WLY is Class A and WLYB is Class B, which is largely held by the Wiley family. On most matters each Class A share carries one-tenth of a vote and each Class B share carries a full vote, and for director elections the classes vote separately, with Class A electing 30% of the board and Class B electing the remaining 70%. Economic rights and dividends are the same per share; WLY is far more liquid, with ~42.0 million shares outstanding versus ~8.8 million of Class B.
How do you invest in WLY?
+
WLY trades on the New York Stock Exchange and is available at any US broker that offers listed equities, including through fractional orders where a broker supports them. In Walnut you can place it inside a basket alongside other holdings, set a target weight for it, and track how the position tracks against that target over time.
Is Wiley an AI winner or an AI casualty?
+
Both arguments are live and the company discloses both. AI licensing brought in ~$49 million in fiscal 2026 and has passed ~$110 million cumulatively, with named partnerships including IQVIA and OpenEvidence. Wiley's own risk factors also state that AI could disrupt its markets, increase competition and cannibalize sales of existing products. The ~$49 million is roughly 3% of revenue, so the licensing engine has to compound for several more years before it decides the outcome.
When does Wiley report earnings?
+
Wiley's fiscal year ends April 30, so its reporting calendar is offset a quarter from most US companies. Fiscal 2026 fourth-quarter and full-year results were released June 16, 2026, and the 10-K was filed June 24, 2026. First-quarter fiscal 2027 results, covering the quarter ended July 31, 2026, are expected in early September 2026. No results were reported in the week of August 25, 2026.
What did Wiley buy with Emerald Publishing?
+
Emerald is a UK scholarly publisher founded in 1967, bought from Cambridge Information Group for £337.5 million (~$452 million) in an all-cash deal that closed June 1, 2026. It brings nearly 500 journal brands, ~8,000 book titles and a case-study archive concentrated in economics, business, finance and management, taking Wiley's portfolio to ~2,500 titles. Wiley expects it to add ~$78 million of fiscal 2027 revenue and ~$0.10 of adjusted EPS, and to dilute free cash flow by ~$15 million in year one.
Does WLY pay a dividend?
+
Yes. Wiley paid ~$1.42 per share on an annualized basis in fiscal 2026 and raised the dividend for a 32nd consecutive year. Total shareholder returns reached a record ~$174 million in fiscal 2026, including ~$100 million of buybacks under a ~$250 million repurchase authorization approved in the first quarter of that year.
Why has the stock moved so much over the past year?
+
The 52-week range of roughly ~$28 to ~$57 is a wide band for a company whose revenue was flat. The re-rating tracked the AI content-licensing narrative, the record margins reported in fiscal 2026, and the Emerald deal, while the pullbacks have tracked skepticism about how durable licensing revenue is and continued declines in Learning.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with John Wiley & Sons, Inc.'s investor relations page or your broker before making investment decisions.